Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE8878.7552.05 (+0.59 %)

PREV CLOSE ( ) 8826.70

OPEN PRICE ( ) 8751.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 725

TODAY'S LOW / HIGH ( )8650.00 8990.00

52 WK LOW / HIGH ( )6501.6 10653.05

NSE8919.0095 (+1.08 %)

PREV CLOSE( ) 8824.00

OPEN PRICE ( ) 8829.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 8919.00 (36)

VOLUME 9284

TODAY'S LOW / HIGH( ) 8641.00 9000.00

52 WK LOW / HIGH ( )6620.1 10691

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1979

Management Info

Shilpa Divekar Nirula - Chairman - Managing Director

Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone 080 6774 8000

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com/india

Registrars Details

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore

Listing : BSE, NSE

NEWS

10Feb AstraZeneca Pharma gets CDSCO nod to i
AstraZeneca Pharma India has received permission from the Central Drugs..

10Feb AstraZeneca Pharma India informs about
AstraZeneca Pharma India has informed that it has received permission fr..

31Jan AstraZeneca Pharma gets nod to import
AstraZeneca Pharma India has received permission from the Central Drugs..

18Dec AstraZeneca Pharma gets permission for
AstraZeneca Pharma India has received permission from the Central Drugs..

18Dec AstraZeneca Pharma rises on getting pe
Astrazeneca Pharma India is currently trading at Rs. 9090.00, up by 64.2..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	325.9	1157.4
Gross Profit	465.4	1563.6
Operating Profit	499.6	2946
Net Sales	6115.7	17162.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 13043.80 (0.65%)	M.Cap ( in Cr)16735.05
Kwality Pharma (BSE) 1431.20 (5.08%)	M.Cap ( in Cr)1485.04
Sanofi Cons. Health (BSE) 4299.65 (1.54%)	M.Cap ( in Cr)9902.36
NGL Fine-Chem (BSE) 2291.65 (2.29%)	M.Cap ( in Cr)1415.79
Haleos Labs (BSE) 1355.75 (3.19%)	M.Cap ( in Cr)409.88

Shareholding Pattern

	PROMOTERS	75%
	NON-INSTITUTION	16.74%
	MUTUAL FUNDS/UTI	5.43%
	FI/BANKS/INSURANCE	0.05%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Samco Flexi Cap Fun...	5.47
Bandhan Innovation ...	3.70
Samco Active Moment...	3.30
Baroda BNP Paribas ...	2.30
Baroda BNP Paribas ...	2.03
Samco ELSS Tax Save...	1.94
DSP Nifty Smallcap2...	1.64

Risk Disclosures on Derivatives

Smart Quotes

ASTRAZENECA PHARMA INDIA LTD.